Cargando…
Loss of E-Cadherin Leads to Druggable Vulnerabilities in Sphingolipid Metabolism and Vesicle Trafficking
SIMPLE SUMMARY: Germline loss of the CDH1 gene is the primary genetic basis for hereditary diffuse gastric cancer, a disease resulting in elevated risk of both diffuse gastric cancer and lobular breast cancer. Current preventative treatment consists of prophylactic total gastrectomy, a therapy with...
Autores principales: | Brew, Tom, Bougen-Zhukov, Nicola, Mitchell, Wilson, Decourtye, Lyvianne, Schulpen, Emily, Nouri, Yasmin, Godwin, Tanis, Guilford, Parry |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8749886/ https://www.ncbi.nlm.nih.gov/pubmed/35008266 http://dx.doi.org/10.3390/cancers14010102 |
Ejemplares similares
-
E-Cadherin-Deficient Epithelial Cells Are Sensitive to HDAC Inhibitors
por: Decourtye-Espiard, Lyvianne, et al.
Publicado: (2021) -
E-Cadherin-Deficient Cells Are Sensitive to the Multikinase Inhibitor Dasatinib
por: Bougen-Zhukov, Nicola, et al.
Publicado: (2022) -
Allosteric AKT Inhibitors Target Synthetic Lethal Vulnerabilities in E-Cadherin-Deficient Cells
por: Bougen-Zhukov, Nicola, et al.
Publicado: (2019) -
E-cadherin-deficient cells have synthetic lethal vulnerabilities in plasma membrane organisation, dynamics and function
por: Godwin, Tanis D., et al.
Publicado: (2018) -
E-cadherin signal sequence disruption: a novel mechanism underlying hereditary cancer
por: Figueiredo, Joana, et al.
Publicado: (2018)